Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis

NCT02039401 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Helixmith Co., Ltd.